Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Shares, par value $0.0000000341740141 per share
-
Shares outstanding
-
695,088,397
-
Total 13F shares
-
339,213,133
-
Share change
-
+334,782,349
-
Total reported value
-
$3,416,732,000
-
Price per share
-
$10.08
-
Number of holders
-
40
-
Value change
-
+$3,374,252,821
-
Number of buys
-
36
Institutional Holders of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) as of Q4 2021
As of 31 Dec 2021 Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) had 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 339,213,133 shares of stock of the company.
Largest 10 holders included QVT Financial LP, SB INVESTMENT ADVISERS (UK) LTD, VIKING GLOBAL INVESTORS LP, SC CHINA HOLDING Ltd, BlackRock Inc., Palantir Technologies Inc., FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, and Founders Fund VI Management, LLC.
This table shows 40 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.